Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Drug-drug interactions between antiretroviral and immunosuppressive agents in HIV-infected patients after solid organ transplantation: a review.

van Maarseveen EM, Rogers CC, Trofe-Clark J, van Zuilen AD, Mudrikova T.

AIDS Patient Care STDS. 2012 Oct;26(10):568-81. doi: 10.1089/apc.2012.0169. Review.

PMID:
23025916
2.

Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients.

Frassetto LA, Browne M, Cheng A, Wolfe AR, Roland ME, Stock PG, Carlson L, Benet LZ.

Am J Transplant. 2007 Dec;7(12):2816-20. Epub 2007 Oct 19.

3.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
4.

The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.

Jain AK, Venkataramanan R, Shapiro R, Scantlebury VP, Potdar S, Bonham CA, Ragni M, Fung JJ.

Liver Transpl. 2002 Sep;8(9):841-5.

5.

Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience.

van Heeswijk RP, Veldkamp A, Mulder JW, Meenhorst PL, Lange JM, Beijnen JH, Hoetelmans RM.

Antivir Ther. 2001 Dec;6(4):201-29. Review.

PMID:
11878403
6.

Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs.

Tricot L, Teicher E, Peytavin G, Zucman D, Conti F, Calmus Y, Barrou B, Duvivier C, Fontaine C, Welker Y, Billy C, de Truchis P, Delahousse M, Vittecoq D, Salmon-Céron D.

Am J Transplant. 2009 Aug;9(8):1946-52. doi: 10.1111/j.1600-6143.2009.02684.x. Epub 2009 Jun 10.

7.

Antiretroviral and immunosuppressive drug-drug interactions in human immunodeficiency virus-infected liver and kidney transplant recipients.

Marfo K, Greenstein S.

Transplant Proc. 2009 Nov;41(9):3796-9. doi: 10.1016/j.transproceed.2009.06.186.

PMID:
19917390
8.

Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV-1 infected liver and kidney transplant recipients.

Frassetto L, Floren L, Barin B, Browne M, Wolfe A, Roland M, Stock P, Carlson L, Christians U, Benet L.

Biopharm Drug Dispos. 2013 Nov;34(8):442-51. doi: 10.1002/bdd.1860. Epub 2013 Sep 12.

9.

Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients.

Frassetto L, Baluom M, Jacobsen W, Christians U, Roland ME, Stock PG, Carlson L, Benet LZ.

Transplantation. 2005 Jul 15;80(1):13-7.

PMID:
16003227
10.

The development of anti-HIV-1 drugs.

Lu XF, Chen ZW.

Yao Xue Xue Bao. 2010 Feb;45(2):165-76. Review.

PMID:
21348415
11.

New antiretroviral drugs.

Hanson K, Hicks C.

Curr HIV/AIDS Rep. 2006 Jul;3(2):93-101. Review.

PMID:
16608666
12.

Simultaneous pancreas-kidney transplantation in HIV-infected patients: a case report and literature review.

Miro JM, Ricart MJ, Trullas JC, Cofan F, Cervera C, Brunet M, Tuset M, Manzardo C, Oppenheimer F, Moreno A.

Transplant Proc. 2010 Nov;42(9):3887-91. doi: 10.1016/j.transproceed.2010.09.003. Review.

PMID:
21094878
13.

New antiretroviral drugs.

Gulick RM.

Clin Microbiol Infect. 2003 Mar;9(3):186-93. Review.

14.

[Organ transplants for HIV-infected patients--time for reevaluation?].

Katzenstein TL.

Ugeskr Laeger. 2005 Nov 14;167(46):4356-8. Danish.

PMID:
16287518
15.

Newer antiretroviral agents and how to use them.

Kim HH, Daar ES.

Curr HIV/AIDS Rep. 2009 May;6(2):55-62. Review.

PMID:
19358775
16.

Infections in solid organ transplant HIV-infected patients.

Miro JM, Agüero F, Duclos-Vallée JC, Mueller NJ, Grossi P, Moreno A; ESCMID Study Group of Infection in Compromised Hosts.

Clin Microbiol Infect. 2014 Sep;20 Suppl 7:119-30. doi: 10.1111/1469-0691.12754. Review.

17.

Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients.

Vogel M, Voigt E, Michaelis HC, Sudhop T, Wolff M, Türler A, Sauerbruch T, Rockstroh JK, Spengler U.

Liver Transpl. 2004 Jul;10(7):939-44.

18.

Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients.

Pea F, Tavio M, Pavan F, Londero A, Bresadola V, Adani GL, Furlanut M, Viale P.

Antivir Ther. 2008;13(5):739-42.

PMID:
18771060
19.

Pretransplantation pharmacokinetic curves of tacrolimus in HIV-infected patients on ritonavir-containing cART: a pilot study.

van Maarseveen EM, Crommelin HA, Mudrikova T, van den Broek MP, van Zuilen AD.

Transplantation. 2013 Jan 27;95(2):397-402. doi: 10.1097/TP.0b013e3182734651.

PMID:
23250333
20.

Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients.

Jain AB, Venkataramanan R, Eghtesad B, Marcos A, Ragni M, Shapiro R, Rafail AB, Fung JJ.

Liver Transpl. 2003 Sep;9(9):954-60.

Items per page

Supplemental Content

Write to the Help Desk